These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 19729969

  • 21. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z, Zhang J, Zhang S, Li L.
    Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
    [Abstract] [Full Text] [Related]

  • 22. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C.
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [Abstract] [Full Text] [Related]

  • 23. Longterm followup of childhood lupus nephritis.
    Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E.
    J Rheumatol; 2002 Dec; 29(12):2635-42. PubMed ID: 12465165
    [Abstract] [Full Text] [Related]

  • 24. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
    Uchino A, Tsukamoto H, Nakashima H, Yoshizawa S, Furugo I, Mitoma H, Oryoji K, Shimoda T, Niiro H, Tada Y, Yano T, Nonaka T, Oishi R, Akashi K, Horiuchi T.
    Clin Exp Rheumatol; 2010 Dec; 28(1):6-12. PubMed ID: 20346231
    [Abstract] [Full Text] [Related]

  • 25. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

  • 26. Treatment and renal outcome of lupus nephritis: single center experience.
    Go KW, Teo SM.
    Med J Malaysia; 2006 Oct; 61(4):447-50. PubMed ID: 17243522
    [Abstract] [Full Text] [Related]

  • 27. Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients.
    Kawai S, Yamamoto K.
    Rheumatology (Oxford); 2006 Apr; 45(4):441-4. PubMed ID: 16263777
    [Abstract] [Full Text] [Related]

  • 28. Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids.
    Pepper R, Griffith M, Kirwan C, Levy J, Taube D, Pusey C, Lightstone L, Cairns T.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3717-23. PubMed ID: 19617257
    [Abstract] [Full Text] [Related]

  • 29. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [Abstract] [Full Text] [Related]

  • 30. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study.
    Mok CC, Tong KH, To CH, Siu YP, Au TC.
    Kidney Int; 2005 Aug; 68(2):813-7. PubMed ID: 16014060
    [Abstract] [Full Text] [Related]

  • 31. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB.
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [Abstract] [Full Text] [Related]

  • 32. [Lupus nephritis: retrospective analysis of the course of the disease].
    Djukanović L, Pavlović S, Blagojević R, Dimitrijević J, Stojsic T, Ratković M, Kazić K, Lezaić V, Naumović R.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
    [Abstract] [Full Text] [Related]

  • 33. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [Abstract] [Full Text] [Related]

  • 34. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK, Rohr MS, Hartmann EL, Adams PL, Stratta RJ.
    Clin Transplant; 2004 Jun; 18 Suppl 12():61-6. PubMed ID: 15217410
    [Abstract] [Full Text] [Related]

  • 35. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [Abstract] [Full Text] [Related]

  • 36. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.
    Reitamo S, Rustin M, Harper J, Kalimo K, Rubins A, Cambazard F, Brenninkmeijer EE, Smith C, Berth-Jones J, Ruzicka T, Sharpe G, Taieb A, 0.1% Tacrolimus Ointment Long-term Follow-up Study Group.
    Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 38. Three-month experience with tacrolimus once-daily regimen in stable renal allografts.
    Diez Ojea B, Alonso Alvarez M, Aguado Fernández S, Baños Gallardo M, García Melendreras S, Gómez Huertas E.
    Transplant Proc; 2009 May; 41(6):2323-5. PubMed ID: 19715908
    [Abstract] [Full Text] [Related]

  • 39. Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up.
    Moroni G, Gallelli B, Quaglini S, Banfi G, Rivolta E, Messa P, Ponticelli C.
    Nephrol Dial Transplant; 2006 Jun; 21(6):1541-8. PubMed ID: 16455674
    [Abstract] [Full Text] [Related]

  • 40. Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study.
    Chrysochou C, Randhawa H, Reeve R, Waldek S, Wood GN, O'Donoghue DJ, Kalra PA.
    QJM; 2008 Apr; 101(4):313-6. PubMed ID: 18270227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.